Key Takeaways SLP's Q3 EPS rose 67% to $0.45 on 10% revenue growth, beating estimates on Pro-ficiency strength. Organic sales fell 4% as biosimulation softness and cautious client spending pressured growth. SLP slashed its 2025 revenue forecast by 15% due to delays, cancellations and weaker services.Simulations Plus, Inc. ((SLP) reported third-quarter fiscal 2025 adjusted earnings of 45 cents per share, which expanded 66.7% year over year. The figure also surpassed the Zacks Consensus Estimate of 26 cents ...